Europe Pushes Alternative to Waiving Patents on Covid-19 Vaccines

June 4, 2021

(Wall Street Journal) – The European Union is pushing back hard against U.S.-backed calls to temporarily waive intellectual property rights for Covid-19 vaccines, preparing a rival plan that officials said would better safeguard drug companies’ patents and look for other ways to boost supplies for developing countries. As the gap between vaccine haves and have-nots has widened, Washington and China have endorsed a proposal by developing countries at the World Trade Organization to suspend patent protections for the immunizations. (Read Full Article)